Future science OA · 2025
Assessment of the relationship between hematologic parameters, (CPD), in screening for COVID-19 severity in women.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
de Carvalho Simone Cristina, Raboni Sonia Mara, Bueno Lucas Bochnia, Lapinscki Bruna Amaral, Lissa Sonia Maria, Amadeu Ludmilla Louise Moreira, Petterle Ricardo Rasmussen, Comar Samuel Ricardo, Nogueira Meri Bordignon
Аннотация
AIMS: This study evaluated hematological parameters and cell population data (CPDs) to assess their ability to discriminate between moderate and severe COVID-19 in hospitalized female patients, and to identify potential markers associated with worse outcomes.
PATIENTS & METHODS: A retrospective study was conducted on 84 adult female COVID-19 patients hospitalized at CHC-UFPR (Brazil) between March 2020 and July 2021. Patients were stratified into moderate (n = 46) and severe (n = 38) disease groups. A control group included 100 healthy female outpatients. Parameters analyzed included D-dimer, WBC count, neutrophil-to-lymphocyte ratio (NLR), and CPDs (LY-X, LY-Y). RT-qPCR was used for SARS-CoV-2 confirmation and variant identification.
RESULTS: Significant differences (p < 0.05) in LY-X, LY-Y, NLR, and WBC were found between moderate and severe groups. D-dimer was elevated in severe cases. Among deceased patients (n = 17), WBC and NLR were markedly increased. ROC curve analysis confirmed the discriminatory power of these markers. No significant association was found between viral genotype and severity (p = 0.9602).
CONCLUSIONS: Hematological parameters, particularly CPDs and NLR, are valuable for early stratification of COVID-19 severity. These automated, rapid, and cost-effective measures can support clinical decision-making. However, CPD usage depends on analyzer availability and lacks standardization across platforms.
PATIENTS & METHODS: A retrospective study was conducted on 84 adult female COVID-19 patients hospitalized at CHC-UFPR (Brazil) between March 2020 and July 2021. Patients were stratified into moderate (n = 46) and severe (n = 38) disease groups. A control group included 100 healthy female outpatients. Parameters analyzed included D-dimer, WBC count, neutrophil-to-lymphocyte ratio (NLR), and CPDs (LY-X, LY-Y). RT-qPCR was used for SARS-CoV-2 confirmation and variant identification.
RESULTS: Significant differences (p < 0.05) in LY-X, LY-Y, NLR, and WBC were found between moderate and severe groups. D-dimer was elevated in severe cases. Among deceased patients (n = 17), WBC and NLR were markedly increased. ROC curve analysis confirmed the discriminatory power of these markers. No significant association was found between viral genotype and severity (p = 0.9602).
CONCLUSIONS: Hematological parameters, particularly CPDs and NLR, are valuable for early stratification of COVID-19 severity. These automated, rapid, and cost-effective measures can support clinical decision-making. However, CPD usage depends on analyzer availability and lacks standardization across platforms.